These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 30513105

  • 1. Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models.
    Ceccarelli F, Sciandrone M, Perricone C, Galvan G, Cipriano E, Galligari A, Levato T, Colasanti T, Massaro L, Natalucci F, Spinelli FR, Alessandri C, Valesini G, Conti F.
    PLoS One; 2018; 13(12):e0207926. PubMed ID: 30513105
    [Abstract] [Full Text] [Related]

  • 2. Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
    Ceccarelli F, Perricone C, Colasanti T, Massaro L, Cipriano E, Pendolino M, Natalucci F, Mancini R, Spinelli FR, Valesini G, Conti F, Alessandri C.
    Arthritis Res Ther; 2018 Jun 14; 20(1):126. PubMed ID: 29898764
    [Abstract] [Full Text] [Related]

  • 3. Erosive arthritis in systemic lupus erythematosus: application of cluster analysis.
    Ceccarelli F, Natalucci F, Pirone C, Olivieri G, Colasanti T, Picciariello L, Spinelli FR, Alessandri C, Conti F.
    Clin Exp Rheumatol; 2022 Nov 14; 40(11):2175-2178. PubMed ID: 36305362
    [Abstract] [Full Text] [Related]

  • 4. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
    Li Y, Jia R, Liu Y, Tang S, Ma X, Shi L, Zhao J, Hu F, Li Z.
    Lupus; 2020 Mar 14; 29(3):239-247. PubMed ID: 31930936
    [Abstract] [Full Text] [Related]

  • 5. Erosive arthritis in systemic lupus erythematosus: not only Rhupus.
    Ceccarelli F, Natalucci F, Olivieri G, Perricone C, Pirone C, Spinelli FR, Alessandri C, Conti F.
    Lupus; 2021 Nov 14; 30(13):2029-2041. PubMed ID: 34666547
    [Abstract] [Full Text] [Related]

  • 6. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.
    Ziegelasch M, van Delft MA, Wallin P, Skogh T, Magro-Checa C, Steup-Beekman GM, Trouw LA, Kastbom A, Sjöwall C.
    Arthritis Res Ther; 2016 Dec 03; 18(1):289. PubMed ID: 27912793
    [Abstract] [Full Text] [Related]

  • 7. Anti-Carbamylated Protein Antibodies in ACPA-Negative and ACPA-Positive Patients with Rheumatoid Arthritis.
    Dibrov DA, Avdeeva AS, Diatroptov ME, Nasonov EL.
    Dokl Biochem Biophys; 2024 Aug 03; 517(1):235-242. PubMed ID: 39002007
    [Abstract] [Full Text] [Related]

  • 8. Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?
    Taraborelli M, Inverardi F, Fredi M, Ceribelli A, Cavazzana I, Tincani A, Franceschini F.
    Reumatismo; 2012 Dec 11; 64(5):321-5. PubMed ID: 23256108
    [Abstract] [Full Text] [Related]

  • 9. Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.
    Massaro L, Ceccarelli F, Colasanti T, Pendolino M, Perricone C, Cipriano E, Natalucci F, Capalbo G, Lucchetti R, Pecani A, Vomero M, Mancini R, Spinelli FR, Alessandri C, Valesini G, Conti F.
    Lupus; 2018 Jan 11; 27(1):105-111. PubMed ID: 28592200
    [Abstract] [Full Text] [Related]

  • 10. Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and ultrasonographic features.
    Ceccarelli F, Massaro L, Perricone C, Pendolino M, Cipriano E, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G, Conti F.
    Clin Exp Rheumatol; 2017 Jan 11; 35(4):674-677. PubMed ID: 28339366
    [Abstract] [Full Text] [Related]

  • 11. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort.
    Truchetet ME, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C, Blanco P, Mahler M, Contin-Bordes C, Schaeverbeke T, Fédération Hospitalo-Universitaire ACRONIM.
    Arthritis Rheumatol; 2017 Dec 11; 69(12):2292-2302. PubMed ID: 28853240
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Elsayed SA, Esmail MA, Ali RM, Mohafez OM.
    Clin Rheumatol; 2019 Oct 11; 38(10):2683-2689. PubMed ID: 31161487
    [Abstract] [Full Text] [Related]

  • 13. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status.
    Ball EM, Tan AL, Fukuba E, McGonagle D, Grey A, Steiner G, Bell AL, Rooney MR.
    Rheumatology (Oxford); 2014 Oct 11; 53(10):1835-43. PubMed ID: 24850876
    [Abstract] [Full Text] [Related]

  • 14. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
    Zhao Y, Li J, Li XX, Li C, Li L, Li ZG.
    Joint Bone Spine; 2009 Oct 11; 76(5):501-7. PubMed ID: 19289297
    [Abstract] [Full Text] [Related]

  • 15. Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus.
    Orsolini G, Mastropaolo F, Favaro E, Piccinelli A, Bertelle D, Viapiana O, Rossini M, Bixio R.
    Clin Rheumatol; 2023 Nov 11; 42(11):3083-3088. PubMed ID: 37195373
    [Abstract] [Full Text] [Related]

  • 16. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
    Boeters DM, Trouw LA, van der Helm-van Mil AHM, van Steenbergen HW.
    Arthritis Res Ther; 2018 May 03; 20(1):94. PubMed ID: 29724250
    [Abstract] [Full Text] [Related]

  • 17. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
    Ten Brinck RM, van Steenbergen HW, van Delft MAM, Verheul MK, Toes REM, Trouw LA, van der Helm-van Mil AHM.
    Rheumatology (Oxford); 2017 Dec 01; 56(12):2145-2153. PubMed ID: 28968865
    [Abstract] [Full Text] [Related]

  • 18. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.
    Kakumanu P, Sobel ES, Narain S, Li Y, Akaogi J, Yamasaki Y, Segal MS, Hahn PC, Chan EK, Reeves WH, Satoh M.
    J Rheumatol; 2009 Dec 01; 36(12):2682-90. PubMed ID: 19884269
    [Abstract] [Full Text] [Related]

  • 19. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ.
    Ann Rheum Dis; 2001 Jan 01; 60(1):67-8. PubMed ID: 11114286
    [Abstract] [Full Text] [Related]

  • 20. Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines).
    Westra J, Brouwer E, Raveling-Eelsing E, Arends S, Eman Abdulle A, Roozendaal C, van Delft MAM, Toes REM, Trouw LA, Vissink A, de Smit MJ.
    Rheumatology (Oxford); 2021 Feb 01; 60(2):658-666. PubMed ID: 32594174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.